Denosumab (anti-RANK ligand), 1mg*5

Denosumab (anti-RANK ligand), 1mg*5

Tremelimumab (anti-CTLA-4), 1mg

Tremelimumab (anti-CTLA-4), 1mg

Denosumab (anti-RANK ligand), 1mg*25

19.336,31 RON
SKU
SKM_A2020_1mg*25

Denosumab (anti-RANK ligand) (AMG-162) is a fully human monoclonal antibody that selectively inhibits primate RANKL. Denosumab inhibits the ability of human RANKL (143–317) to stimulate the formation of osteoclasts derived from murine RAW 264.7 cells with an IC50 value of 1.64 nM.

Mai multe informatii
Price 16.249,00 RON (preturile sunt fara TVA)
Description

Denosumab (anti-RANK ligand) (AMG-162) is a fully human monoclonal antibody that selectively inhibits primate RANKL. Denosumab inhibits the ability of human RANKL (143–317) to stimulate the formation of osteoclasts derived from murine RAW 264.7 cells with an IC50 value of 1.64 nM.